SEHK:2252Medical Equipment
Shanghai MicroPort MedBot SEHK 2252 Narrows EPS Loss Challenging Persistent Bearish Profitability Narratives
Shanghai MicroPort MedBot (Group) (SEHK:2252) reported FY 2025 first half revenue of C¥175.7 million with a basic EPS loss of C¥0.11, setting the tone for another period where top line expansion and bottom line pressure sit side by side for investors tracking the story at a share price of C¥25.74. The company has seen revenue build from C¥99.2 million in 1H 2024 to C¥158.0 million in 2H 2024 and then to C¥175.7 million in 1H 2025. Over the same period, basic EPS moved from a loss of C¥0.29 to...